Profil
Peter Friedman worked as a Director-Product Formulation & Master Chemist at Valor Medical, Inc. He completed his undergraduate degree at Tel-Aviv University and his graduate degree at Weizmann Institute of Science.
He also earned a doctorate degree from Weizmann Institute of Science in 1996.
Anciens postes connus de Peter Friedman
| Sociétés | Poste | Fin |
|---|---|---|
Valor Medical, Inc.
 Valor Medical, Inc. Medical SpecialtiesHealth Technology Valor Medical, Inc. develops injectable medical devices. It operates as a medical device company that develops a liquid embolic and malleable polymetric flow diverter technology for the treatment of cerebral aneurysms. The firm provides Neucrylate, a derivative of cyanoacrylate monomer, which changes from liquid to a sponge like material when it comes in contact with blood. Its product serves various neurological applications. The company was founded by Charles W. Kerber in 2007 and is headquartered in San Diego, CA. | Corporate Officer/Principal | - |
Formation de Peter Friedman
| Tel-Aviv University | Undergraduate Degree |
| Weizmann Institute of Science | Graduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 1 |
|---|---|
Valor Medical, Inc.
Valor Medical, Inc. Medical SpecialtiesHealth Technology Valor Medical, Inc. develops injectable medical devices. It operates as a medical device company that develops a liquid embolic and malleable polymetric flow diverter technology for the treatment of cerebral aneurysms. The firm provides Neucrylate, a derivative of cyanoacrylate monomer, which changes from liquid to a sponge like material when it comes in contact with blood. Its product serves various neurological applications. The company was founded by Charles W. Kerber in 2007 and is headquartered in San Diego, CA. | Health Technology |
